Hongbao Jia

No ORCID on file · 1 paper in corpus
observational 2024
Diagnostic pathology ·doi:10.1186/s13000-024-01510-4

BACKGROUND: Ovarian clear cell carcinoma (OCCC), well known for its chemoresistance to platinum-based chemotherapy, exhibited a good response in clinical trials of anti-PD-1/PD-L1 inhibitors. By assessing PD-L1 expression, we sought to dete…